Buffalo Supply seemed to be pretty much limited to listing Arch products in their catalog. A long established business that is somewhat passive in nature. Which may work fine for them but I don’t think it’s what Arch needs right now.
Lovell Med falls under service disabled vet owned business which assures them a piece of the quota pie so there’s a level of market share right up front.
Lovell Med also states that they work with their partners in maximizing sales. Their literature states they have helped to secure $400M in contracts.
To me Lovell Med seems more assertive and hungry.
The change on the Arch side is adding a sales person. In my general opinion finance people aren’t good at sales and sales people aren’t good at finance. I suspect that Norchi was rather conflicted before help arrived.
I’m happy to see Arch get another run at it. I’m also managing my expectations.